Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

DiaMedica Therapeutics Inc. (DMAC) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

DiaMedica Therapeutics Inc. (DMAC), most recent 12 months reported: net loss $37.54M, free cash flow -$31.54M. Latest balance sheet on file: liquid cash $43.5M. From SEC filings. Others in Pharmaceutical Preparations: Cadrenal Therapeutics, Inc. · CYTODYN INC. · CYPHERPUNK TECHNOLOGIES INC. · Decoy Therapeutics Inc. · DAMORA THERAPEUTICS, INC. · Dermata Therapeutics, Inc. · Design Therapeutics, Inc. · Dogwood Therapeutics, Inc.

Stock screener

Watchlist